Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical and Experimental Rheumatology is Scopus-indexed (Q1, CiteScore 5.8), WoS SCIE. Published by Clinical and Experimental Rheumatology S.A.S..
Checked against the index lists dated .
ISSN 0392-856XVerify ISSN ↗1593-098XVerify ISSN ↗
Publisher: Clinical and Experimental Rheumatology S.A.S.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Rheumatology | 17 / 77 | 78th | Q1 |
| Immunology and Allergy | 92 / 234 | 60th | Q2 |
| Immunology | 101 / 243 | 58th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1983–present, best quartile Q1, CiteScore 5.8.
Clinical and Experimental Rheumatology is Q1 in Rheumatology (rank 17 of 77), Q2 in Immunology and Allergy (rank 92 of 234) and Q2 in Immunology (rank 101 of 243), by CiteScore 2025.
Clinical and Experimental Rheumatology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.8, which places it in quartile Q1 at the 78th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.038, quartile Q2, with an H-index of 114.
Clinical and Experimental Rheumatology is published by Clinical and Experimental Rheumatology S.A.S. Its print ISSN is 0392-856X and its online ISSN is 1593-098X.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Clinical and Experimental Rheumatology has an h-index of 40 and a 2-year mean of 1.24 citations per paper (OpenAlex). Its Scopus CiteScore is 5.8, quartile Q1. On 2-year citations it ranks #44 of 74 Scopus journals in Rheumatology.
Clinical and Experimental Rheumatology published 332 papers in 2025; its busiest recent year was 2021 with 557. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from Italy (32.6%), Türkiye (9.3%) and United States (9.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.